Azione 002873 GUIYANG XINTIAN PHARMACEUTICAL CO.,LTD.
Aggiungi a un elenco
Solo clienti o iscritti possono usare questa funzione
AccediRegistrati

Altre lingue Guiyang Xintian Pharmaceutical Co.,Ltd.

Azioni

002873

CNE100002QB5

Prezzo di chiusura Shenzhen S.E.
Altri mercati azionari
 00:00:00 26/06/2024 		Variaz. 5gg Var. 1 gen.
8,59 CNY +3,49% Grafico intraday di Guiyang Xintian Pharmaceutical Co.,Ltd. -3,59% -31,06%
03/06 Xintian Pharmaceutical ottiene l'autorizzazione a sperimentare un farmaco per la prostatite cronica non batterica; le azioni scendono del 3%. MT
27/04 Guiyang Xintian Pharmaceutical Co.,Ltd. riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024 CI

Altre lingue

Ricerca
Vedi i risultati
Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!
Registrazione 100% gratuita
Guiyang Xintian Pharmaceutical Co.,Ltd. Announces Final Dividend on A Shares for the Year 2023, Payable on 25 June 2024
Xintian Pharmaceutical Gets Nod to Trial Chronic Non-Bacterial Prostatitis Drug; Shares Down 3%
Guiyang Xintian Pharmaceutical Co.,Ltd. Approves Cash Dividend for 2023
Guiyang Xintian Pharmaceutical Co.,Ltd.'s Equity Buyback announced on February 6, 2024, has expired with 8,806,030 shares, representing 3.81% for CNY 75.3 million.
Guiyang Xintian Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Guiyang Xintian Pharmaceutical Co.,Ltd. Announces Profit Distribution Proposal for 2023
Guiyang Xintian Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Guiyang Xintian Pharmaceutical Co.,Ltd. signed Transaction Framework Agreement to acquire remaining 85.12% stake in Shanghai Huilun Biotechnology Co., Ltd.
Tranche Update on Guiyang Xintian Pharmaceutical Co.,Ltd.'s Equity Buyback Plan announced on February 6, 2024.
Guiyang Xintian Pharmaceutical Co.,Ltd. announces an Increase in Equity Buyback.
Guiyang Xintian Pharmaceutical Co.,Ltd. announces an Equity Buyback for CNY 50 million worth of its shares.
Guiyang Xintian Pharmaceutical Co.,Ltd. authorizes a Buyback Plan.
Tranche Update on Guiyang Xintian Pharmaceutical Co.,Ltd.'s Equity Buyback Plan announced on December 23, 2023.
Guiyang Xintian Pharmaceutical Co.,Ltd.'s Equity Buyback announced on December 23, 2023 has closed with 4,017,200 shares, representing 1.73% for CNY 38.41 million.
Guiyang Xintian Pharmaceutical Co.,Ltd. announces an Increase in Equity Buyback.
Tranche Update on Guiyang Xintian Pharmaceutical Co.,Ltd.'s Equity Buyback Plan announced on December 23, 2023.
Guiyang Xintian Pharmaceutical Co.,Ltd. announces an Equity Buyback for CNY 15 million worth of its shares.
Guiyang Xintian Pharmaceutical Co.,Ltd. authorizes a Buyback Plan.
Guiyang Xintian Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Guiyang Xintian Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Non ci sono risultati per questa ricerca
Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Filtri

Cerca

Data di pubblicazione

Da

A

  1. Borsa valori
  2. Azioni
  3. Azione 002873
  4. Notizie Guiyang Xintian Pharmaceutical Co.,Ltd.
  5. Altre lingue